Author:
Yang He,Li Xian,Yang Xinyi,Lu Panpan,Wang Yanan,Jiang Zhengtao,Pan Hanyu,Zhao Lin,Zhu Yuqi,Khan Inam Ullah,Shen Yinzhong,Lu Hongzhou,Zhang Tong,Jiang Guochun,Ma Zhongjun,Wu Hao,Zhu Huanzhang
Funder
National Grand Program on Key Infectious Disease, China
National Natural Science Foundation of China
Qura Therapuetics, United States
University of North Carolina at Chapel Hill Center for AIDS Research
Reference68 articles.
1. Ingenol mebutate gel (picato) : a novel agent for the treatment of actinic keratoses;Fidler;PT,2014
2. Dual role of novel ingenol derivatives from Euphorbia tirucalli in HIV replication: inhibition of de novo infection and activation of viral LTR;Abreu;PLoS One,2014
3. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy;Archin;Nature,2012
4. Eradicating HIV-1 infection: seeking to clear a persistent pathogen;Archin;Nat. Rev. Microbiol.,2014
5. Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency;Archin;J. Clin. Investig.,2017
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献